{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:51:19Z","timestamp":1794009079257,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126525","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T19:11:07Z","timestamp":1732302667000},"page":"126525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P1","title":["Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines"],"prefix":"10.1016","volume":"43","author":[{"given":"Nicholas S.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen C.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Akintunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustina F.","family":"Blackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovelyn","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Henri","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvanus","family":"Okogbenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Paessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Pinschewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia L.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126525_bb0005","series-title":"Lassa fever situation report: Epi week 32","author":"NCfDCA","year":"2024"},{"key":"10.1016\/j.vaccine.2024.126525_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006187","article-title":"Lassa fever-induced sensorineural hearing loss: a neglected public health and social burden","volume":"12","author":"Mateer","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.126525_bb0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from west Africa. I. Clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126525_bb0020","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2024.126525_bb0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/trstmh\/tru009","article-title":"Constraints in the diagnosis and treatment of Lassa fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone","volume":"108","author":"Dahmane","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126525_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00405-010-1370-4","article-title":"Early-onset sensorineural hearing loss in Lassa fever","volume":"268","author":"Ibekwe","year":"2011","journal-title":"Eur Arch Otorrinolaringol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2020.08.021","article-title":"Lassa fever induced hearing loss: the neglected disability of hemorrhagic fever","volume":"100","author":"Ficenec","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126525_bb0040","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute sensorineural deafness in Lassa fever","volume":"264","author":"Cummins","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126525_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4269\/ajtmh.1973.22.780","article-title":"Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, march-April 1972","volume":"22","author":"Mertens","year":"1973","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.126525_bb0050","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1080\/00016480600702084","article-title":"Idiopathic sudden hearing loss: contradictory clinical evidence, placebo effects and high spontaneous recovery rate--where do we stand in assessing treatment outcomes?","volume":"126","author":"Finger","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0055","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.1990.03450160089037","article-title":"Deafness associated with Lassa fever","volume":"264","author":"Rybak","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126525_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/mrdd.10088","article-title":"Early intervention after universal neonatal hearing screening: impact on outcomes","volume":"9","author":"Yoshinaga-Itano","year":"2003","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.vaccine.2024.126525_bb0065","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1037\/a0024238","article-title":"Hearing loss and cognition in the Baltimore longitudinal study of aging","volume":"25","author":"Lin","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.vaccine.2024.126525_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010557","article-title":"CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model","volume":"18","author":"Maruyama","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.126525_bb0075","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/JVI.02948-15","article-title":"Animal model of sensorineural hearing loss associated with Lassa virus infection","volume":"90","author":"Yun","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1997.tb01003.x","article-title":"What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?","volume":"159","author":"Klenerman","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2024.126525_bb0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chom.2017.07.008","article-title":"Interferon-gamma-driven iNOS: a molecular pathway to terminal shock in arenavirus hemorrhagic fever","volume":"22","author":"Remy","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2024.126525_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/238335a0","article-title":"Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease","volume":"238","author":"Cole","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.126525_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.1824801","article-title":"Vaccination for disease","volume":"251","author":"Oehen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.126525_bb0100","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0105","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126525_bb0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.126525_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"Flatz","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.126525_bb0120","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.06284-11","article-title":"Functional interferon system is required for clearance of Lassa virus","volume":"86","author":"Yun","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0125","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1128\/JVI.01433-13","article-title":"Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus","volume":"87","author":"Yun","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072290","article-title":"Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers","volume":"8","author":"Rieger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126525_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005656","article-title":"Chimeric mice with competent hematopoietic immunity reproduce key features of severe Lassa fever","volume":"12","author":"Oestereich","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.126525_bb0140","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","article-title":"A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever","volume":"13","author":"Cashman","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126525_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201847772","article-title":"Residual LCMV antigen in transiently CD4(+) T cell-depleted mice induces high levels of virus-specific antibodies but only limited B-cell memory","author":"Schweier","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2016.138","article-title":"Immunobiology of Ebola and Lassa virus infections","volume":"17","author":"Prescott","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0155","first-page":"9","article-title":"Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following Lassa virus exposure in cynomolgus macaques","author":"Cashman","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2024.126525_bb0160","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.otc.2021.08.007","article-title":"Mechanisms of ototoxicity and otoprotection","volume":"54","author":"Steyger","year":"2021","journal-title":"Otolaryngol Clin N Am"},{"key":"10.1016\/j.vaccine.2024.126525_bb0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1121\/10.0011739","article-title":"The audiogram: detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear","volume":"152","author":"le Prell","year":"2022","journal-title":"J Acoust Soc Am"},{"key":"10.1016\/j.vaccine.2024.126525_bb0170","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1097\/MAO.0000000000001134","article-title":"Serial monitoring of otoacoustic emissions in clinical trials","volume":"37","author":"Konrad-Martin","year":"2016","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0175","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40264-017-0629-8","article-title":"Drug-induced ototoxicity: diagnosis and monitoring","volume":"41","author":"Campbell","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2024.126525_bb0180","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2471\/BLT.21.285643","article-title":"The world report on hearing, 2021","volume":"99","author":"Chadha","year":"2021","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.126525_bb0185","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1080\/14992027.2017.1417644","article-title":"Clinical trials, ototoxicity grading scales and the audiologist\u2019s role in therapeutic decision making","volume":"57","author":"King","year":"2018","journal-title":"Int J Audiol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0190","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.vaccine.2020.05.019","article-title":"Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"38","author":"Carol Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126525_bb0195","series-title":"National institutes of health, department of health and human services","author":"(NCI) NCI. Common Terminology Criteria for Adverse Event (CTCAE v. 5.0)","year":"2017"},{"key":"10.1016\/j.vaccine.2024.126525_bb0200","series-title":"Audiologic management of individuals receiving cochleotoxic drug therapy","first-page":"1","author":"American Speech-Language-Hearing Association (ASHA)","year":"1994"},{"key":"10.1016\/j.vaccine.2024.126525_bb0205","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new international society of pediatric oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","article-title":"Ototoxicity (cochleotoxicity) classifications: a review","volume":"55","author":"Crundwell","year":"2016","journal-title":"Int J Audiol"},{"key":"10.1016\/j.vaccine.2024.126525_bb0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126525_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111094","article-title":"A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever","volume":"40","author":"Cross","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2024.126525_bb0225","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(23)00048-X","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial","volume":"401","author":"Tschismarov","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126525_bb0230","series-title":"Lassa fever vaccine trial","author":"IAVIC102","year":"2023"},{"key":"10.1016\/j.vaccine.2024.126525_bb0235","series-title":"Adverse effects of vaccines: Evidence and causality","author":"Institute of Medicine.","year":"2012"},{"key":"10.1016\/j.vaccine.2024.126525_bb0240","first-page":"493","article-title":"Uses and abuses of hearing loss classification","volume":"23","author":"Clark","year":"1981","journal-title":"ASHA"},{"key":"10.1016\/j.vaccine.2024.126525_bb0245","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2471\/BLT.19.230367","article-title":"Hearing loss grades and the international classification of functioning, disability and health","volume":"97","author":"Olusanya","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.126525_bb0250","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/0194599815593737","article-title":"Accuracy of a tablet audiometer for measuring behavioral hearing thresholds in a clinical population","volume":"153","author":"Thompson","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2024.126525_bb0255","series-title":"Clinical trials: Design, conduct and analysis","author":"Meinert","year":"2012"},{"key":"10.1016\/j.vaccine.2024.126525_bb0260","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/14760584.2015.1038249","article-title":"Adversomics: a new paradigm for vaccine safety and design","volume":"14","author":"Whitaker","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.126525_bb0265","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/cid\/ciac407","article-title":"Advancing the science of vaccine safety during the coronavirus disease 2019 (COVID-19) pandemic and beyond: launching an international network of special immunization services","volume":"75","author":"Top","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126525_bb0270","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41467-019-08794-x","article-title":"Dynamic molecular changes during the first week of human life follow a robust developmental trajectory","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126525_bb0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fped.2020.00197","article-title":"Clinical protocol for a longitudinal cohort study employing systems biology to identify markers of vaccine immunogenicity in newborn infants in the Gambia and Papua New Guinea","volume":"8","author":"Idoko","year":"2020","journal-title":"Front Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:43:27Z","timestamp":1734018207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"alternative-id":["S0264410X24012076"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126525","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126525"}}